3M Co. (MMM-N)

They report soon and he expects a good report, but nobody will care. Big internationals are frowned upon, unless you hold through the cycle.

He bought it at 12x PE, now at 19x. The new CEO demonstrates they can change their business.

So much is about sentiment and the street expects a massive cut to earnings. We haven't seen their full-year estimates. 

They're in the second inning of their turnaround, and shares remain cheap. Expectations remain low.

It's a turnaround story, so he initiated a position. He is selective in industrials, because they trade at a 24x forward PE, higher than the S&P.

It trades at only 17x PE in 3M, and it runs a diversified business.

Wait. Don't enter this now. Wants to see more clarity. Shares are climbing after a long malaise and they have a new CEO. But hey have legacy problems with a chemical and a huge lawsuit, and the noise suppression technology lawsuit. These types of companies do turn around, but he'd rather pay more for more certainty.

Large industrial with a medical component, and she likes that. Good job getting back on track. Dividend cut earlier this year.

She focuses more on Canadian companies, so take a look at CCL.B. 

Long-term underperformer and base-building, recently broke out. Resistance levels started to fall, one by one. Then big pop on earnings. One of the top-ranked stocks on RSI in the US universe, acting extremely well. Quite well supported, even through the correction of last week.

Last Friday, the CEO walked about areas that could see cost cuts and many segments that could grow faster. MMM is part of the rally broadening out of tech.

Just reported: beat earnings and revenues and free cash flow. Also, they guided a little higher. The CEO is focused on growing organic growth, free cash flow and operating margins, which is what happened and will do. She would still buy it.

He thinks the CEO can continue to turn things around and expand operating margins.

The new CEO is doing what he must and has a good track record from L3Harris.

All their lawsuits have put this in the penalty box as the business struggles and the dividend was cut in half.

Was upgraded today. Most calls remain sell. This is a turnaround story, but shares are cheap at 14x. They cut the dividend, now 2.8% but it remains higher than the industry average of 1.8%. They spun-off their healthcare business, so the company is simplifying. The current CEO as a good, massive track record from L3Harris and UTX. Will buy on any weakness.